Increased CXCL9 and CXCL10 expression and presence of CXCR3+ T cells in the cerebrospinal fluid (CSF) of the MS patients indicate the implication of CXCR3 in the MS lesion formation. This evidence concerns the gene CXCL9 and myeloid sarcoma.